Clinical Trials Sponsored by Labafi Nejad Eye Research Center

Total 161 results

Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin) (Bevacizumab)

Diabetic Retinopathy

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

Pilot Study to Evaluate Levodopa as Treatment for Residual Amblyopia (ATS14)

Amblyopia

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

Observational Study of Optical Correction for Strabismic Amblyopia in Children 3 to <7 Years Old (ATS13)

Amblyopia

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

Full-time Bangerter Filters Versus Part-time Daily Patching for Moderate Amblyopia in Children (ATS10)

Amblyopia

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

Increasing Patching for Amblyopia in Children 3 to < 8 Years Old (ATS15)

Amblyopia

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

Trial Comparing Patching Versus Atropine for Amblyopia in 7 to < 13 Year Olds (ATS9)

Amblyopia

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

Levodopa for the Treatment of Residual Amblyopia (ATS17)

Amblyopia

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

Trial Comparing Part-time Versus Full-time Patching for Severe Amblyopia

Amblyopia

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

Trial Comparing Daily Atropine Versus Weekend Atropine

Amblyopia

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

Trial Comparing Near Versus Distance Activities While Patching for Amblyopia in Children 3 to <7 Years Old (ATS6)

Amblyopia

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

An Evaluation of Treatment of Amblyopia in Children 7 To <18 Years Old

Amblyopia

United States
Jaeb Center for Health Research
National Eye Institute (NEI); Pediatric Eye Disease Investigator Group

Not yet recruiting

Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age (ATS23)

Amblyopia
Jaeb Center for Health Research
National Eye Institute (NEI); Pediatric Eye Disease Investigator Group

Recruiting

A Randomized Trial to Evaluate Sequential vs Simultaneous Patching (ATS22)

Amblyopia

United States
Jaeb Center for Health Research
National Eye Institute (NEI); Pediatric Eye Disease Investigator Group

Completed

A Prospective Observational Study of Adult Strabismus (SAS1)

Convergence Insufficiency | Divergence Insufficiency | Hypertropia

United States
Jaeb Center for Health Research
National Eye Institute (NEI); Pediatric Eye Disease Investigator Group

Completed

Binocular Dig Rush Game Treatment for Amblyopia (ATS20)

Amblyopia

United States, Canada
Jaeb Center for Health Research
National Eye Institute (NEI); Pediatric Eye Disease Investigator Group

Completed

Observation Versus Occlusion Therapy for Intermittent Exotropia (IXT2)

Exotropia

United States
Jaeb Center for Health Research
National Eye Institute (NEI); Pediatric Eye Disease Investigator Group

Completed

Study of Binocular Computer Activities for Treatment of Amblyopia (ATS18)

Amblyopia

United States
Jaeb Center for Health Research
National Eye Institute (NEI); Pediatric Eye Disease Investigator Group

Completed

A Pilot Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia (IXT3)

Intermittent Exotropia

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)

Diabetic Macular Edema

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N) (N)

Proliferative Diabetic Retinopathy | Vitreous Hemorrhage

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

Observational Study of DME Following Scatter Laser Photocoagulation (PRP)

Diabetic Macular Edema
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

The Course of Response to Focal Photocoagulation for DME (Laser Resp)

Diabetic Retinopathy | Diabetic Macular Edema

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

Correction of Myopia Evaluation Trial 2 (COMET2)

Myopia

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

Trial Comparing Atropine to Atropine Plus a Plano Lens for the Sound Eye for Amblyopia in Children 3 to <7 Years Old (ATS8)

Amblyopia

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

Immediate Office Probing vs Deferred Facility Probing for Nasolacrimal Duct Obstruction in Children 6 to <10 Months Old (NLD3)

Nasolacrimal Duct Obstruction

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

Trial Comparing Part-time Versus Minimal-time Patching for Moderate Amblyopia (ATS2B)

Amblyopia

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

Study of Primary Surgical Treatment of Nasolacrimal Duct Obstruction in Children Less Than Four Years Old (NLD1)

Nasolacrimal Duct Obstruction

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

Augmenting Atropine Treatment for Amblyopia in Children 3 to < 8 Years Old (ATS16)

Amblyopia

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

A Pilot Study of Peribulbar Triamcinolone Acetonide for Diabetic Macular Edema (Peribulbar)

Diabetic Macular Edema
Jaeb Center for Health Research
National Eye Institute (NEI)

Terminated

Trial Comparing Patching With Active Vision Therapy to Patching With Control Vision Therapy as Treatment for Amblyopia (ATS12)

Amblyopia

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Terminated

Combined Patching-Atropine for Residual Amblyopia (ATS11)

Amblyopia

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

Occlusion Versus Pharmacologic Therapy for Moderate Amblyopia

Amblyopia

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

Study of Surgical Procedures for Treatment of Persistent Nasolacrimal Duct Obstruction in Children < 4 Years Old (NLD2)

Nasolacrimal Duct Obstruction

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

An Observational Study of Infantile, Acquired Non-accommodative, and Acquired Partially-accommodative Esotropia

Infantile Esotropia | Acquired Non-accommodative Esotropia | Acquired Partially Accommodative Esotropia

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

Bilateral Refractive Amblyopia Treatment Study (ATS7)

Bilateral Refractive Amblyopia

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

Trial to Evaluate 2 Hours of Daily Patching for Amblyopia in Children

Amblyopia

United States
Louis Tong
Singapore Eye Research Institute; SEED Company Pte Ltd

Completed

Effect of Contact Lens With Alginic Acid in Dry Eye Patients

Dry Eyes

Singapore
The Eye Center and The Eye Foundation for Research...
King Khalid University Hospital

Completed

Hydroxychloroquine Dosing and Toxicity in Ophthalmology Clinics

Hydroxychloroquine Toxic Retinopathy

Saudi Arabia
Dr Salouti Eye Research Center
Shiraz University of Medical Sciences

Unknown

Safety and Efficacy of Lotemax Versus FML in Subjects Undergoing PRK for the Correction of Mild to Moderate Myopia, 3- Month Follow-up Study

Must be PRK Candidate
Jaeb Center for Health Research
National Eye Institute (NEI); Allergan

Completed

Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema (IVT)

Diabetic Macular Edema

United States
Singapore National Eye Centre
National Medical Research Council (NMRC), Singapore; Singapore Eye Research... and other collaborators

Completed

Autologous ex Vivo Conjunctival Epithelial Cell Expansion for Ocular Surface Transplantation

Pterygium | Ocular Surface Disease | Chemical Injury | Stevens Johnson Syndrome

Singapore
Singapore National Eye Centre
National Medical Research Council (NMRC), Singapore

Active, not recruiting

The Use of Atropine 0.01% in the Prevention and Control of Myopia (ATOM3)

Myopia

Singapore
Singapore National Eye Centre
National Medical Research Council (NMRC), Singapore

Unknown

Asymptomatic Narrow Angles - Laser Iridotomy Study; Multicentric RCT

Asymptomatic Narrow Angles | Primary Angle Closure Suspects

Singapore
Manhattan Eye, Ear & Throat Hospital
Alcon Research; LuEsther T. Mertz Retinal Research Center

Completed

Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate (CSC-AA)

Chronic Central Serous Chorioretinopathy

United States
King Khaled Eye Specialist Hospital
King Faisal Specialist Hospital & Research Center

Completed

Trial of Subretinal Injection of (rAAV2-VMD2-hMERTK)

Retinitis Pigmentosa | Retinal Disease

Saudi Arabia
Jaeb Center for Health Research
National Eye Institute (NEI); Genentech, Inc.

Completed

Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy (Protocol S)

Proliferative Diabetic Retinopathy

United States
Manhattan Eye, Ear & Throat Hospital
LuEsther T. Mertz Retinal Research Center

Completed

A Pilot Study of the Treatment of Central Serous Chorioretinopathy With Ketoconazole (CSC/Keto)

Chronic Central Serous Chorioretinopathy

United States
Singapore Eye Research Institute
University of Melbourne; Curtin University; Singapore National Eye Centre; Ministry...

Unknown

Living Successfully With Chronic Eye Diseases (ADAPT-LAH)

Glaucoma | Diabetic Retinopathy | Age-related Macular Degeneration | Low Vision | Chronic Diseases

Singapore
Jaeb Center for Health Research
National Eye Institute (NEI); Genentech, Inc.; Allergan

Completed

Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema (LRT for DME)

Diabetic Retinopathy | Diabetic Macular Edema

United States
Jaeb Center for Health Research
National Eye Institute (NEI); Genentech, Inc.; Allergan

Completed

Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy (LRTforDME+PRP)

Diabetic Macular Edema | Proliferative Diabetic Retinopathy

United States

Clinical Trials Sponsored by Labafi Nejad Eye Research Center

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Singapore

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations